With a market capitalization (market cap) of $1.64B — a measure of how much the company is worth — Omnicell, Inc. is the 2246th most valuable company in Healthcare as of August 19, 2026. Shares trade at $35.97, down +0.17% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Visit websiteAs of August 19, 2026, Omnicell, Inc. (OMCL) is worth $1.64B — this is its market capitalization, the total value of all its outstanding shares.
Omnicell, Inc.’s market cap is $1.64B, which ranks it #2246 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Omnicell, Inc. (OMCL) shares trade at $35.97, down 0.17% on the day, as of August 19, 2026.
Omnicell, Inc. trades at a price-to-earnings (P/E) ratio of 806.5, based on its latest share price and annual earnings per share.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025